Timing in antibiotic therapy: when and how to start, de-escalate and stop antibiotic therapy. Proposals from a stablished antimicrobial stewardship program
Rev. esp. quimioter
; 35(Supl. 3): 102-107, Oct. 2022. ilus
Artigo
em Inglês
| IBECS
| ID: ibc-210759
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
The current morbimortality of serious infections is unacceptable and there is a need to promote the increase in the efficacy of empirical and targeted antibiotherapy. This could be achieved by initiatives coming from ASP teams aimed at promoting increased efficacy of antibiotic therapy .In the optimization of the antibiotic therapy there are several critical points in which an adequate timing could achieve benefits in the survival of patients with severe infections prompt initiation of empirical treatment; de-escalation performance, appropriate targeted treatment; and finally, curtail antibiotic duration. (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Bactérias
/
Anti-Infecciosos
/
Antibacterianos
Limite:
Humanos
Idioma:
Inglês
Revista:
Rev. esp. quimioter
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Hospital Universitario Virgen de la Nieves/Spain